These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16313350)

  • 21. Estrogen regulation of immune cell bone interactions.
    Weitzmann MN; Pacifici R
    Ann N Y Acad Sci; 2006 Apr; 1068():256-74. PubMed ID: 16831927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral osteoporosis: a review and its dental implications].
    Inagaki K; Kurosu Y; Sakano M; Yamamoto G; Kikuchi T; Noguchi T; Yano H; Izawa H; Hachiya Y
    Clin Calcium; 2007 Feb; 17(2):157-63. PubMed ID: 17272871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen modulates bone marrow-derived DCs in SLE murine model-(NZB x NZW) F1 female mice.
    Jiang B; Sun L; Hao S; Li X; Xu Y; Hou Y
    Immunol Invest; 2008; 37(3):227-43. PubMed ID: 18389442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators.
    Härkönen PL; Väänänen HK
    Ann N Y Acad Sci; 2006 Nov; 1089():218-27. PubMed ID: 17261769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
    Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide and bone.
    Wimalawansa SJ
    Ann N Y Acad Sci; 2010 Mar; 1192():391-403. PubMed ID: 20392265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators.
    Verdier-Sévrain S
    Climacteric; 2007 Aug; 10(4):289-97. PubMed ID: 17653955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormones and osteoporosis update. Estrogen and bone remodeling].
    Kato S
    Clin Calcium; 2009 Jul; 19(7):951-6. PubMed ID: 19567990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice.
    Bynoté KK; Hackenberg JM; Korach KS; Lubahn DB; Lane PH; Gould KA
    Genes Immun; 2008 Mar; 9(2):137-52. PubMed ID: 18200028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogens and antiestrogens as etiological factors and therapeutics for prostate cancer.
    Ho SM; Leung YK; Chung I
    Ann N Y Acad Sci; 2006 Nov; 1089():177-93. PubMed ID: 17261766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL; Chao HT; Cheng MH; Wang PH
    Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?
    Silvestri S; Thomsen AB; Gozzini A; Bagger Y; Christiansen C; Brandi ML
    Menopause; 2006; 13(3):451-61. PubMed ID: 16735942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis.
    Morón FJ; Mendoza N; Vázquez F; Molero E; Quereda F; Salinas A; Fontes J; Martínez-Astorquiza T; Sánchez-Borrego R; Ruiz A
    Bone; 2006 Jul; 39(1):213-21. PubMed ID: 16530497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Raloxifene (Evista) in the treatment of postmenopausal osteoporosis--the profile of the patient].
    Kastelan D; Korsić M
    Reumatizam; 2005; 52(2):67-70. PubMed ID: 16689133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
    Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia.
    Mhyre AJ; Dorsa DM
    Neuroscience; 2006; 138(3):851-8. PubMed ID: 16343790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice.
    Cho NL; Javid SH; Carothers AM; Redston M; Bertagnolli MM
    Cancer Res; 2007 Mar; 67(5):2366-72. PubMed ID: 17332369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy.
    Dijsselbloem N; Vanden Berghe W; De Naeyer A; Haegeman G
    Biochem Pharmacol; 2004 Sep; 68(6):1171-85. PubMed ID: 15313415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-function relationship of estrogen receptor alpha and beta: impact on human health.
    Ascenzi P; Bocedi A; Marino M
    Mol Aspects Med; 2006 Aug; 27(4):299-402. PubMed ID: 16914190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis.
    Kung AW; Chu EY; Xu L
    Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.